Literature DB >> 22239234

Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.

Benjamin J Umlauf1, Iana H Haralambieva, Inna G Ovsyannikova, Richard B Kennedy, V Shane Pankratz, Robert M Jacobson, Gregory A Poland.   

Abstract

Measles remains a public health concern due to a lack of vaccine use and vaccine failure. A better understanding of the factors that influence variations in immune responses, including innate/inflammatory and adaptive cellular immune responses, following measles-mumps-rubella (MMR) vaccination could increase our knowledge of measles vaccine-induced immunity and potentially lead to better vaccines. Measles-specific innate/inflammatory and adaptive cell-mediated immune (CMI) responses were characterized using enzyme-linked immunosorbent assays to quantify the levels of secreted IL-2, IL-6, IL-10, IFN-α, IFN-γ, IFN-λ1, and TNF-α in PBMC cultures following in vitro stimulation with measles virus (MV) in a cohort of 764 school-aged children. IFN-γ ELISPOT assays were performed to ascertain the number of measles-specific IFN-γ-secreting cells. Cytokine responses were then tested for associations with self-declared demographic data, including gender, race, and ethnicity. Females secreted significantly more TNF-α, IL-6, and IFN-α (p<0.001, p<0.002, p<0.04, respectively) compared to males. Caucasians secreted significantly more IFN-λ1, IL-10, IL-2, TNF-α, IL-6, and IFN-α (p<0.001, p<0.001, p<0.001, p<0.003, p<0.01, and p<0.02, respectively) compared to the other racial groups combined. Additionally, Caucasians had a greater number of IFN-γ-secreting cells compared to other racial groups (p<0.001). Ethnicity was not significantly correlated with variations in measles-specific CMI measures. Our data suggest that innate/inflammatory and CMI cytokine responses to measles vaccine vary significantly by gender and race. These data further advance our understanding regarding inter-individual and subgroup variations in immune responses to measles vaccination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22239234      PMCID: PMC3271368          DOI: 10.1089/vim.2011.0051

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  53 in total

1.  The changing epidemiology of hospitalized pediatric patients in three measles outbreaks.

Authors:  Kyung-Yil Lee; Hyung-Shin Lee; Jae-Kyun Hur; Jin-Han Kang; Byung-Churl Lee
Journal:  J Infect       Date:  2006-04-18       Impact factor: 6.072

2.  Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.

Authors:  Bernard J Cohen; Susette Audet; Nick Andrews; Judy Beeler
Journal:  Vaccine       Date:  2007-11-12       Impact factor: 3.641

Review 3.  Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.

Authors:  G A Poland; I G Ovsyannikova; R M Jacobson; D I Smith
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

4.  Seroprevalence of measles antibody in the US population, 1999-2004.

Authors:  Geraldine M McQuillan; Deanna Kruszon-Moran; Terri B Hyde; Bagher Forghani; William Bellini; Gustavo H Dayan
Journal:  J Infect Dis       Date:  2007-11-01       Impact factor: 5.226

5.  Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29).

Authors:  W J Jordan; J Eskdale; M Boniotto; M Rodia; D Kellner; G Gallagher
Journal:  Genes Immun       Date:  2006-11-02       Impact factor: 2.676

6.  Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect?

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert M Jacobson; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Cytokine       Date:  2007-01-17       Impact factor: 3.861

7.  HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Virology       Date:  2007-03-30       Impact factor: 3.616

8.  Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

Authors:  W J Jordan; J Eskdale; S Srinivas; V Pekarek; D Kelner; M Rodia; G Gallagher
Journal:  Genes Immun       Date:  2007-03-15       Impact factor: 2.676

9.  Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Vaccine       Date:  2004-05-07       Impact factor: 3.641

10.  Cytokine production patterns and antibody response to measles vaccine.

Authors:  Inna G Ovsyannikova; Karlene C Reid; Robert M Jacobson; Ann L Oberg; George G Klee; Gregory A Poland
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

View more
  29 in total

1.  Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2013-06-24       Impact factor: 2.850

Review 2.  Adversomics: a new paradigm for vaccine safety and design.

Authors:  Jennifer A Whitaker; Inna G Ovsyannikova; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2015-05-02       Impact factor: 5.217

Review 3.  Sex-based differences in immune function and responses to vaccination.

Authors:  Sabra L Klein; Ian Marriott; Eleanor N Fish
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

Review 4.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

5.  Changing face of vaccination in immunocompromised hosts.

Authors:  Daire O'Shea; Lukas A Widmer; Jörg Stelling; Adrian Egli
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

Review 6.  Sex-based biology and the rational design of influenza vaccination strategies.

Authors:  Sabra L Klein; Andrew Pekosz
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

7.  Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay.

Authors:  Scott D Painter; Iana H Haralambieva; Inna G Ovsyannikova; Diane E Grill; Gregory A Poland
Journal:  Viral Immunol       Date:  2014-03       Impact factor: 2.257

Review 8.  The first steps towards the era of personalised vaccinology: predicting adverse reactions.

Authors:  P Pellegrino; F S Falvella; V Perrone; C Carnovale; T Brusadelli; M Pozzi; S Antoniazzi; S Cheli; C Perrotta; E Clementi; S Radice
Journal:  Pharmacogenomics J       Date:  2014-10-07       Impact factor: 3.550

9.  Long-chain peer referral to recruit black MSM and black transgender women for an HIV vaccine efficacy trial.

Authors:  Angela Coombs; Willi McFarland; Theresa Ick; Vincent Fuqua; Susan P Buchbinder; Jonathan D Fuchs
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

Review 10.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.